The Supreme Court on Thursday dismissed a challenge to the common abortion drug mifepristone, saying the plaintiffs lacked standing.
The ruling means the drug, used in the majority of abortions, may continue to be prescribed online and shipped by mail, upholding recent regulatory changes made by the Food and Drug Administration.
The decision by the high court was unanimous and written by Justice Brett Kavanaugh, an appointee of former President Donald Trump. It marks a major victory for the Biden administration, which, since 2022, has sought to fight against efforts by anti-abortion groups to limit access to abortifacients in the wake of the landmark decision overturning Roe v. Wade.